Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129655) titled 'Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Cholangitis Post Kasai in Biliary Atresia)' on Aug. 11.
Study Type: Observational [Patient Registry]
Primary Sponsor: University Hospital, Geneva
Condition:
Biliary Atresia, Kasai Portoenterostomy Status
Cholangitis
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2025
Target Sample Size: 40
Countries of Recruitment:
Switzerland
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07129655
Disclaimer: Curated by HT Syndication....